Sameer S. Kadri, MD, MS, FIDSA

Intensivist and Head, Clinical Epidemiology Section, Critical Care Medicine Department
National Institutes of Health Clinical Center

Poster(s):

• (175) Clindamycin versus linezolid for Group A Streptococcal bloodstream infections?: A comparative effectiveness study of adjunctive antitoxin therapy at 137 US Hospitals
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET